- Home
- IBIO vs FEMY Comparison
IBIO vs FEMY Comparison
Compare IBIO & FEMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IBIO
- FEMY
- Stock Information
- Founded
- IBIO 2008
- FEMY 2004
- Country
- IBIO United States
- FEMY United States
- Employees
- IBIO N/A
- FEMY N/A
- Industry
- IBIO Biotechnology: Pharmaceutical Preparations
- FEMY Medical/Dental Instruments
- Sector
- IBIO Health Care
- FEMY Health Care
- Exchange
- IBIO Nasdaq
- FEMY Nasdaq
- Market Cap
- IBIO 23.4M
- FEMY 24.9M
- IPO Year
- IBIO N/A
- FEMY 2021
- Fundamental
- Price
- IBIO $2.30
- FEMY $0.95
- Analyst Decision
- IBIO Strong Buy
- FEMY Strong Buy
- Analyst Count
- IBIO 2
- FEMY 3
- Target Price
- IBIO $4.30
- FEMY $10.00
- AVG Volume (30 Days)
- IBIO 97.9K
- FEMY 245.5K
- Earning Date
- IBIO 11-12-2024
- FEMY 11-12-2024
- Dividend Yield
- IBIO N/A
- FEMY N/A
- EPS Growth
- IBIO N/A
- FEMY N/A
- EPS
- IBIO N/A
- FEMY N/A
- Revenue
- IBIO $175,000.00
- FEMY $1,260,643.00
- Revenue This Year
- IBIO N/A
- FEMY $135.27
- Revenue Next Year
- IBIO N/A
- FEMY $310.75
- P/E Ratio
- IBIO N/A
- FEMY N/A
- Revenue Growth
- IBIO 250.00
- FEMY 15.33
- 52 Week Low
- IBIO $0.25
- FEMY $0.73
- 52 Week High
- IBIO $6.20
- FEMY $2.40
- Technical
- Relative Strength Index (RSI)
- IBIO 40.07
- FEMY 31.56
- Support Level
- IBIO $2.40
- FEMY $1.10
- Resistance Level
- IBIO $2.65
- FEMY $1.18
- Average True Range (ATR)
- IBIO 0.21
- FEMY 0.09
- MACD
- IBIO -0.07
- FEMY -0.04
- Stochastic Oscillator
- IBIO 27.49
- FEMY 0.62
About IBIO iBio Inc.
iBio Inc is a preclinical stage biotechnology company that leverages the power of Artificial Intelligence (AI) for the development of precision antibodies. CDMO. Its technology stack is designed to minimize downstream development risks by employing AI-guided epitope-steering and monoclonal antibody (mAb) optimization.
About FEMY Femasys Inc.
Femasys Inc is a biomedical company focused on transforming women's healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas. The company's mission is to provide women with minimally invasive, non-surgical product technologies, accessible in the office, improving patient care and overall health economics.